182 related articles for article (PubMed ID: 26216727)
1. The effects of CRF and urocortins on the hippocampal glutamate release.
Bagosi Z; Balangó B; Pintér D; Csabafi K; Jászberényi M; Szabó G; Telegdy G
Neurochem Int; 2015 Nov; 90():67-71. PubMed ID: 26216727
[TBL] [Abstract][Full Text] [Related]
2. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
[TBL] [Abstract][Full Text] [Related]
3. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
4. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
[TBL] [Abstract][Full Text] [Related]
5. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
Bagosi Z; Jászberényi M; Szabó G; Telegdy G
Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090
[TBL] [Abstract][Full Text] [Related]
6. The effects of corticoptropin-releasing factor and the urocortins on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study.
Bagosi Z; Jászberényi M; Bujdosó E; Telegdy G
Neurochem Res; 2006 Feb; 31(2):209-13. PubMed ID: 16518577
[TBL] [Abstract][Full Text] [Related]
7. The effects of the urocortins on the hypothalamic-pituitary-adrenal axis - similarities and discordancies between rats and mice.
Bagosi Z; Csabafi K; Karasz G; Jászberényi M; Földesi I; Siska A; Szabó G; Telegdy G
Peptides; 2019 Feb; 112():1-13. PubMed ID: 30414887
[TBL] [Abstract][Full Text] [Related]
8. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
9. Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata.
Hope PJ; Turnbull H; Farr S; Morley JE; Rice KC; Chrousos GP; Torpy DJ; Wittert GA
Peptides; 2000 May; 21(5):669-77. PubMed ID: 10876049
[TBL] [Abstract][Full Text] [Related]
10. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
Brar BK; Chen A; Perrin MH; Vale W
Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
[TBL] [Abstract][Full Text] [Related]
11. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
12. Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.
Chen P; Vaughan J; Donaldson C; Vale W; Li C
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E337-45. PubMed ID: 19952342
[TBL] [Abstract][Full Text] [Related]
13. Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
Jin L; Zhang Q; Guo R; Wang L; Wang J; Wan R; Zhang R; Xu Y; Li S
J Mol Endocrinol; 2011 Oct; 47(2):219-27. PubMed ID: 21765100
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 1 inhibits rat leydig cell function.
Rivier CL
Endocrinology; 2008 Dec; 149(12):6425-32. PubMed ID: 18719027
[TBL] [Abstract][Full Text] [Related]
15. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
[TBL] [Abstract][Full Text] [Related]
17. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system.
Poliak S; Mor F; Conlon P; Wong T; Ling N; Rivier J; Vale W; Steinman L
J Immunol; 1997 Jun; 158(12):5751-6. PubMed ID: 9190925
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
Flandreau EI; Bourke CH; Ressler KJ; Vale WW; Nemeroff CB; Owens MJ
Psychoneuroendocrinology; 2013 Aug; 38(8):1349-61. PubMed ID: 23267723
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.
Stern CM; Meitzen J; Mermelstein PG
Eur J Neurosci; 2011 Sep; 34(5):671-81. PubMed ID: 21819464
[TBL] [Abstract][Full Text] [Related]
20. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
